Pain Management Devices Market

Markets covered by this analysis include the US, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. More than 100 million people in the US experience chronic pain. In Europe, the prevalence of chronic pain is between 25% and 35%. Pain-related disability represents a significant and costly liability to patients and employers.This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the worldwide TENS, neurostimulators, implantable analgesia infusion pumps, and external analgesia infusion pumps markets. The global market for pain management devices totaled more than $3.2bn in 2016, and is expected to climb at a rate of 4.7% over the forecast period; markets covered by this analysis include the US, Europe, and ROW.